IL-10 in myeloma cells

Leukemia and Lymphoma

Volumn 43, Issue 5, 2002, Pages 969-974

  Otsuki, Takemi ^a   Yata, Kenichiro ^a   Sakaguchi, Haruko ^a   Uno, Masako ^a   Fujii, Tomohiro ^a   Wada, Hideho ^a   Sugihara, Takashi ^a   Ueki, Ayako ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

ATRA; c maf; Gene expression; Interleukin 10; Myeloma

Indexed keywords

ALPHA INTERFERON; CYTOKINE; DEXAMETHASONE; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 11; INTERLEUKIN 6; ONCOSTATIN M; RECOMBINANT INTERLEUKIN 10; RETINOIC ACID; TRANSCRIPTION FACTOR;

CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; CLINICAL STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE PRODUCTION; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0036233930     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190290021579     Document Type: Review

References (48)

1. "Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma"
2. "gp130 in human myeloma/plasmacytoma"
3. "Cytokine network in human multiple myeloma"
4. "Biological aspects of multiple myeloma"
5. "Role of cytokines in multiple myeloma"
6. "Autocirne generation and requirement of BSF-2/IL-6 for human multiple myelomas"
7. "Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266"
8. "Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6"
9. "Macrophages as an important source of paracrine IL-6 in myeloma bone marrow"
10. "Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma"
11. "Immunoreactive interleukin-6 in serum of patients with B-lymphoproliferative diseases"
12. "Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: Correlation with disease activity and other prognostic parameters"
13. "Serum levels of interleukin-6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias"
14. "The interleukin-6 receptor alpha-chain (CD-126) is expressed by neoplastic but not normal plasma cells"
15. "A role for insulin-like growth factor in the regulation of IL-6-responsive human myeloma cell line growth"
16. "Functional role of cation-independent mannose 6-phosphate/insulin-like growth factor II receptor in cell adhesion and proliferation of a human myeloma cell line OPM-2"
17. "Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines"
18. "Interleukin-15 blocks apoptosis and induces proliferation of the human myeloma cell line OH-2 and freshly isolated myeloma cells"
19. "Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells"
20. "Serum interleukin-10 in early stage multiple myeloma"
21. "Serum interleukin-10 in plasma-cell dyscrasias"
22. "Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in myeloma"
23. "Interleukin-10 induces interleukin-11 responsiveness in human myeloma cell lines"
24. "Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop"
25. "Interleukin-10 and Gp130 cytokines in human multiple myeloma"
26. "Interleukin-10"
27. "Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32)"
28. "Establishment of a new human myeloma cell line, KMS-18, having t(4;14)(p16.3;q32.3) derived from a case who phenotypically transformed from Ig A-λ to BJP-λ, and associated with hyperammonemia"
29. "Genetic and biological characterization of human myeloma cell lines: An overview of the lines established at Kawasaki Medical School"
30. "Estrogen receptors in human myeloma cells"
31. "Expression and production of IL-10 in human myeloma cell lines"
32. "Gene rearrangement and overexpression of PRAD1 gene in lymphoid malignancy with t(11;14)(q13;q32) translocation"
33. "Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma"
34. "Frequent translocation t(4;14) (p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3"
35. "A novel chromosomal translocation t(4;14)(p16.3;q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene"
36. "Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma"
37. "Frequent dysregulation of the c-maf protooncogene at 16q23 by translocation to an Ig locus in multiple myeloma"
38. "Establishment of CD7 + human myeloma sister cell lines, KMS-21-PE and KMS-21-BM, carrying t(11;14) and t(8;14)"
39. "Cell cycle analysis and expression of cell cycle regulator genes in myeloma cells overexpressing cyclin D1"
40. "Structure-function analysis of the maf oncogene product, a member of the b-Zip protein family"
41. "Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction"
42. "Dexamethasone plus retinoids decrease IL-6/IL-6 receptor and induce apoptosis in myeloma cells"
43. "Inhibition of myeloma cell growth by all-trans retinoic acid is associated with upregulation of p21WAF1 and dephosphorylation of the retinoblastoma protein"
44. "Growth inhibition of a human myeloma cell line by all-trans retinoic acid is not mediated through downregulation of interleukin-6 receptors but through upregulation of p21(WAF1)"
45. "In vitro treatment with retinoids decreases bcl-2 protein expression and enchances dexamethasone-induced cytotoxicity and apoptosis in multiple myeloma cells"
46. "All-trans retinoic acid in combination with alpha-interferon and dexamethasone for advanced multiple myeloma"
47. "Assessment of all-trans retinoic acid (ATRA) efficacy as a single agent in primary lymphoid neoplasia"
48. "IL-10 abolishes the growth inhibitory effects of all trans retinoic acid (ATRA) on human myeloma cells"